Switzerland · Series B startup

Who invested in Noema Pharma

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$147Mraised across 1 round since 2024, from 1 source

Latest round
Series B, $147MDec 2024
Investors
4
See who backed them

The rounds

  1. Dec 2024

Founders and team

From Noema Pharma's own website: 4 on the team.

  • Michael SamarChief Financial Officer
  • Michel DavidVP CMC & Clinical Supply
  • Sally NixonHead of Operations
  • Jeffrey JonasChairman

Everyone who backed them

Polaris PartnersVC firm1round
Sofinnova PartnersVC firm1round
Forbion Capital PartnersPrivate equity1round
EQT Life SciencesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Noema Pharma

Who invested in Noema Pharma?

Noema Pharma's investors include Polaris Partners, Sofinnova Partners, Forbion Capital Partners and EQT Life Sciences.

How much has Noema Pharma raised?

Noema Pharma has raised $147M across 1 round since 2024.

When did Noema Pharma last raise?

Noema Pharma's most recent round was a Series B of $147M in Dec 2024.

What was Noema Pharma's biggest round?

Its most recent round, $147M in Dec 2024, is also its largest on record.

Who backed Noema Pharma first?

Noema Pharma's first round on record, in Dec 2024, was backed by Polaris Partners, Sofinnova Partners and Forbion Capital Partners and 1 others.

What stage is Noema Pharma at?

Noema Pharma's latest named round is a Series B, in Dec 2024.

Where is Noema Pharma based?

Noema Pharma is based in Switzerland.

Companies like Noema Pharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.